In the CONNECT trial, CGM users with type 2 diabetes not on insulin saw larger A1C reductions and more time in range than those using finger-stick testing.
|Articles|November 1, 2018
FDA-Approved Diabetes CGM: CEO of Developing Company Talks Potential
Author(s)Stephanie Stephens, MA
How continuous glucose monitors work, how doctors prescribe them, and whether payers are covering them.
Advertisement
How continuous glucose monitors work, how doctors prescribe them, and whether payers are covering them.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
CVS Health is splitting in two, according to news reports
2
Jeremy Gaskill on moving from Humana to Geisinger Health Plan
3
The CVS Health split. How separate will the two companies really be?
4
A Democratic Congress likely means more oversight for payers, not a Medicaid rollback
5